Kirr Marbach Partners Value Fund
Kirr Marbach Partners Value Fund (KMVAX) Stock Competitors & Peer Comparison
See (KMVAX) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KMVAX | $35.77 | +1.88% | 108.7M | N/A | N/A | N/A |
| VTSAX | $156.23 | +2.50% | 2.1T | 24.43 | $6.21 | +1.20% |
| VITSX | $156.26 | +2.50% | 2.1T | 24.43 | $6.21 | +1.32% |
| VSMPX | $293.11 | +2.50% | 2.1T | 24.43 | $11.65 | +1.13% |
| PMFLX | $10.04 | +0.60% | 1.9T | N/A | N/A | N/A |
| VOO | $597.55 | +2.86% | 1.6T | 25.81 | $23.15 | +1.19% |
| VFFSX | $319.44 | +2.52% | 1.5T | 25.09 | $12.37 | N/A |
| VFIAX | $602.47 | +2.52% | 1.5T | 25.09 | $23.33 | +1.12% |
| VFINX | $602.60 | +2.52% | 1.5T | 25.09 | $23.33 | +1.19% |
| BCTK | $23.33 | +5.03% | 1.1T | 41.24 | $0.57 | N/A |
Stock Comparison
KMVAX vs VTSAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VTSAX has a market cap of 2.1T. Regarding current trading prices, KMVAX is priced at $35.77, while VTSAX trades at $156.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VTSAX's P/E ratio is 24.43. In terms of profitability, KMVAX's ROE is N/A, compared to VTSAX's ROE of +0.08%. Regarding short-term risk, KMVAX and VTSAX have similar daily volatility (0.00).Check VTSAX's competition here
KMVAX vs VITSX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VITSX has a market cap of 2.1T. Regarding current trading prices, KMVAX is priced at $35.77, while VITSX trades at $156.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VITSX's P/E ratio is 24.43. In terms of profitability, KMVAX's ROE is N/A, compared to VITSX's ROE of +0.00%. Regarding short-term risk, KMVAX and VITSX have similar daily volatility (0.00).Check VITSX's competition here
KMVAX vs VSMPX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VSMPX has a market cap of 2.1T. Regarding current trading prices, KMVAX is priced at $35.77, while VSMPX trades at $293.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VSMPX's P/E ratio is 24.43. In terms of profitability, KMVAX's ROE is N/A, compared to VSMPX's ROE of N/A. Regarding short-term risk, KMVAX and VSMPX have similar daily volatility (0.00).Check VSMPX's competition here
KMVAX vs PMFLX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, PMFLX has a market cap of 1.9T. Regarding current trading prices, KMVAX is priced at $35.77, while PMFLX trades at $10.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas PMFLX's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to PMFLX's ROE of N/A. Regarding short-term risk, KMVAX and PMFLX have similar daily volatility (0.00).Check PMFLX's competition here
KMVAX vs VOO Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VOO has a market cap of 1.6T. Regarding current trading prices, KMVAX is priced at $35.77, while VOO trades at $597.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VOO's P/E ratio is 25.81. In terms of profitability, KMVAX's ROE is N/A, compared to VOO's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to VOO. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check VOO's competition here
KMVAX vs VFFSX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VFFSX has a market cap of 1.5T. Regarding current trading prices, KMVAX is priced at $35.77, while VFFSX trades at $319.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VFFSX's P/E ratio is 25.09. In terms of profitability, KMVAX's ROE is N/A, compared to VFFSX's ROE of N/A. Regarding short-term risk, KMVAX and VFFSX have similar daily volatility (0.00).Check VFFSX's competition here
KMVAX vs VFIAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VFIAX has a market cap of 1.5T. Regarding current trading prices, KMVAX is priced at $35.77, while VFIAX trades at $602.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VFIAX's P/E ratio is 25.09. In terms of profitability, KMVAX's ROE is N/A, compared to VFIAX's ROE of +0.00%. Regarding short-term risk, KMVAX and VFIAX have similar daily volatility (0.00).Check VFIAX's competition here
KMVAX vs VFINX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VFINX has a market cap of 1.5T. Regarding current trading prices, KMVAX is priced at $35.77, while VFINX trades at $602.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VFINX's P/E ratio is 25.09. In terms of profitability, KMVAX's ROE is N/A, compared to VFINX's ROE of +0.00%. Regarding short-term risk, KMVAX and VFINX have similar daily volatility (0.00).Check VFINX's competition here
KMVAX vs BCTK Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, BCTK has a market cap of 1.1T. Regarding current trading prices, KMVAX is priced at $35.77, while BCTK trades at $23.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas BCTK's P/E ratio is 41.24. In terms of profitability, KMVAX's ROE is N/A, compared to BCTK's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to BCTK. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check BCTK's competition here
KMVAX vs FXAIX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FXAIX has a market cap of 749.1B. Regarding current trading prices, KMVAX is priced at $35.77, while FXAIX trades at $227.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FXAIX's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to FXAIX's ROE of N/A. Regarding short-term risk, KMVAX and FXAIX have similar daily volatility (0.00).Check FXAIX's competition here
KMVAX vs IVV Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, IVV has a market cap of 719.5B. Regarding current trading prices, KMVAX is priced at $35.77, while IVV trades at $653.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas IVV's P/E ratio is 25.79. In terms of profitability, KMVAX's ROE is N/A, compared to IVV's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to IVV. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check IVV's competition here
KMVAX vs VXUS Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VXUS has a market cap of 657.5B. Regarding current trading prices, KMVAX is priced at $35.77, while VXUS trades at $77.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VXUS's P/E ratio is 16.73. In terms of profitability, KMVAX's ROE is N/A, compared to VXUS's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to VXUS. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check VXUS's competition here
KMVAX vs SPY Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, SPY has a market cap of 651.1B. Regarding current trading prices, KMVAX is priced at $35.77, while SPY trades at $650.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas SPY's P/E ratio is 25.80. In terms of profitability, KMVAX's ROE is N/A, compared to SPY's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to SPY. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check SPY's competition here
KMVAX vs VTIAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VTIAX has a market cap of 636.7B. Regarding current trading prices, KMVAX is priced at $35.77, while VTIAX trades at $41.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VTIAX's P/E ratio is 16.17. In terms of profitability, KMVAX's ROE is N/A, compared to VTIAX's ROE of +0.00%. Regarding short-term risk, KMVAX and VTIAX have similar daily volatility (0.00).Check VTIAX's competition here
KMVAX vs VTPSX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VTPSX has a market cap of 636.7B. Regarding current trading prices, KMVAX is priced at $35.77, while VTPSX trades at $164.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VTPSX's P/E ratio is 16.16. In terms of profitability, KMVAX's ROE is N/A, compared to VTPSX's ROE of +0.00%. Regarding short-term risk, KMVAX and VTPSX have similar daily volatility (0.00).Check VTPSX's competition here
KMVAX vs VTSNX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VTSNX has a market cap of 636.7B. Regarding current trading prices, KMVAX is priced at $35.77, while VTSNX trades at $164.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VTSNX's P/E ratio is 16.16. In terms of profitability, KMVAX's ROE is N/A, compared to VTSNX's ROE of +0.00%. Regarding short-term risk, KMVAX and VTSNX have similar daily volatility (0.00).Check VTSNX's competition here
KMVAX vs VTI Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VTI has a market cap of 549.3B. Regarding current trading prices, KMVAX is priced at $35.77, while VTI trades at $320.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VTI's P/E ratio is 25.15. In terms of profitability, KMVAX's ROE is N/A, compared to VTI's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to VTI. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check VTI's competition here
KMVAX vs BMOP Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, BMOP has a market cap of 432.5B. Regarding current trading prices, KMVAX is priced at $35.77, while BMOP trades at $24.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas BMOP's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to BMOP's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to BMOP. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check BMOP's competition here
KMVAX vs QQQ Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, QQQ has a market cap of 405.3B. Regarding current trading prices, KMVAX is priced at $35.77, while QQQ trades at $577.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas QQQ's P/E ratio is 31.07. In terms of profitability, KMVAX's ROE is N/A, compared to QQQ's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to QQQ. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check QQQ's competition here
KMVAX vs VUG Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VUG has a market cap of 347.2B. Regarding current trading prices, KMVAX is priced at $35.77, while VUG trades at $436.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VUG's P/E ratio is 32.16. In terms of profitability, KMVAX's ROE is N/A, compared to VUG's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to VUG. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check VUG's competition here
KMVAX vs VIGIX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VIGIX has a market cap of 335.9B. Regarding current trading prices, KMVAX is priced at $35.77, while VIGIX trades at $224.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VIGIX's P/E ratio is 30.93. In terms of profitability, KMVAX's ROE is N/A, compared to VIGIX's ROE of +0.00%. Regarding short-term risk, KMVAX and VIGIX have similar daily volatility (0.00).Check VIGIX's competition here
KMVAX vs VIGAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VIGAX has a market cap of 335.9B. Regarding current trading prices, KMVAX is priced at $35.77, while VIGAX trades at $224.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VIGAX's P/E ratio is 30.93. In terms of profitability, KMVAX's ROE is N/A, compared to VIGAX's ROE of +0.00%. Regarding short-term risk, KMVAX and VIGAX have similar daily volatility (0.00).Check VIGAX's competition here
KMVAX vs VIIIX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VIIIX has a market cap of 333.2B. Regarding current trading prices, KMVAX is priced at $35.77, while VIIIX trades at $522.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VIIIX's P/E ratio is 24.91. In terms of profitability, KMVAX's ROE is N/A, compared to VIIIX's ROE of +0.00%. Regarding short-term risk, KMVAX and VIIIX have similar daily volatility (0.00).Check VIIIX's competition here
KMVAX vs VINIX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VINIX has a market cap of 331.9B. Regarding current trading prices, KMVAX is priced at $35.77, while VINIX trades at $522.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VINIX's P/E ratio is 24.91. In terms of profitability, KMVAX's ROE is N/A, compared to VINIX's ROE of +0.00%. Regarding short-term risk, KMVAX and VINIX have similar daily volatility (0.00).Check VINIX's competition here
KMVAX vs VEA Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VEA has a market cap of 317.8B. Regarding current trading prices, KMVAX is priced at $35.77, while VEA trades at $64.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VEA's P/E ratio is 17.62. In terms of profitability, KMVAX's ROE is N/A, compared to VEA's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to VEA. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check VEA's competition here
KMVAX vs VTMNX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VTMNX has a market cap of 307.5B. Regarding current trading prices, KMVAX is priced at $35.77, while VTMNX trades at $20.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VTMNX's P/E ratio is 17.04. In terms of profitability, KMVAX's ROE is N/A, compared to VTMNX's ROE of +0.00%. Regarding short-term risk, KMVAX and VTMNX have similar daily volatility (0.00).Check VTMNX's competition here
KMVAX vs VTMGX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VTMGX has a market cap of 307.3B. Regarding current trading prices, KMVAX is priced at $35.77, while VTMGX trades at $20.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VTMGX's P/E ratio is 17.05. In terms of profitability, KMVAX's ROE is N/A, compared to VTMGX's ROE of +0.00%. Regarding short-term risk, KMVAX and VTMGX have similar daily volatility (0.00).Check VTMGX's competition here
KMVAX vs VDIPX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VDIPX has a market cap of 307.3B. Regarding current trading prices, KMVAX is priced at $35.77, while VDIPX trades at $32.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VDIPX's P/E ratio is 17.05. In terms of profitability, KMVAX's ROE is N/A, compared to VDIPX's ROE of +0.00%. Regarding short-term risk, KMVAX and VDIPX have similar daily volatility (0.00).Check VDIPX's competition here
KMVAX vs RLBGX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RLBGX has a market cap of 279B. Regarding current trading prices, KMVAX is priced at $35.77, while RLBGX trades at $36.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RLBGX's P/E ratio is 25.51. In terms of profitability, KMVAX's ROE is N/A, compared to RLBGX's ROE of N/A. Regarding short-term risk, KMVAX and RLBGX have similar daily volatility (0.00).Check RLBGX's competition here
KMVAX vs AFMBX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AFMBX has a market cap of 279B. Regarding current trading prices, KMVAX is priced at $35.77, while AFMBX trades at $36.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AFMBX's P/E ratio is 25.51. In terms of profitability, KMVAX's ROE is N/A, compared to AFMBX's ROE of +0.13%. Regarding short-term risk, KMVAX and AFMBX have similar daily volatility (0.00).Check AFMBX's competition here
KMVAX vs CLBAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, CLBAX has a market cap of 279B. Regarding current trading prices, KMVAX is priced at $35.77, while CLBAX trades at $36.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas CLBAX's P/E ratio is 25.51. In terms of profitability, KMVAX's ROE is N/A, compared to CLBAX's ROE of N/A. Regarding short-term risk, KMVAX and CLBAX have similar daily volatility (0.00).Check CLBAX's competition here
KMVAX vs ABALX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, ABALX has a market cap of 278.6B. Regarding current trading prices, KMVAX is priced at $35.77, while ABALX trades at $36.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas ABALX's P/E ratio is 25.51. In terms of profitability, KMVAX's ROE is N/A, compared to ABALX's ROE of +0.13%. Regarding short-term risk, KMVAX and ABALX have similar daily volatility (0.00).Check ABALX's competition here
KMVAX vs BALFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, BALFX has a market cap of 278.6B. Regarding current trading prices, KMVAX is priced at $35.77, while BALFX trades at $36.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas BALFX's P/E ratio is 25.51. In terms of profitability, KMVAX's ROE is N/A, compared to BALFX's ROE of N/A. Regarding short-term risk, KMVAX and BALFX have similar daily volatility (0.00).Check BALFX's competition here
KMVAX vs AMBFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AMBFX has a market cap of 278.6B. Regarding current trading prices, KMVAX is priced at $35.77, while AMBFX trades at $36.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AMBFX's P/E ratio is 25.51. In terms of profitability, KMVAX's ROE is N/A, compared to AMBFX's ROE of N/A. Regarding short-term risk, KMVAX and AMBFX have similar daily volatility (0.00).Check AMBFX's competition here
KMVAX vs RGAGX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RGAGX has a market cap of 253.4B. Regarding current trading prices, KMVAX is priced at $35.77, while RGAGX trades at $74.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RGAGX's P/E ratio is 26.47. In terms of profitability, KMVAX's ROE is N/A, compared to RGAGX's ROE of N/A. Regarding short-term risk, KMVAX and RGAGX have similar daily volatility (0.00).Check RGAGX's competition here
KMVAX vs GAFFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, GAFFX has a market cap of 253.1B. Regarding current trading prices, KMVAX is priced at $35.77, while GAFFX trades at $74.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas GAFFX's P/E ratio is 26.46. In terms of profitability, KMVAX's ROE is N/A, compared to GAFFX's ROE of N/A. Regarding short-term risk, KMVAX and GAFFX have similar daily volatility (0.00).Check GAFFX's competition here
KMVAX vs AGTHX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AGTHX has a market cap of 252.9B. Regarding current trading prices, KMVAX is priced at $35.77, while AGTHX trades at $73.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AGTHX's P/E ratio is 26.45. In terms of profitability, KMVAX's ROE is N/A, compared to AGTHX's ROE of N/A. Regarding short-term risk, KMVAX and AGTHX have similar daily volatility (0.00).Check AGTHX's competition here
KMVAX vs GFFFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, GFFFX has a market cap of 251.9B. Regarding current trading prices, KMVAX is priced at $35.77, while GFFFX trades at $73.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas GFFFX's P/E ratio is 26.46. In terms of profitability, KMVAX's ROE is N/A, compared to GFFFX's ROE of N/A. Regarding short-term risk, KMVAX and GFFFX have similar daily volatility (0.00).Check GFFFX's competition here
KMVAX vs GFAFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, GFAFX has a market cap of 250.2B. Regarding current trading prices, KMVAX is priced at $35.77, while GFAFX trades at $73.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas GFAFX's P/E ratio is 26.44. In terms of profitability, KMVAX's ROE is N/A, compared to GFAFX's ROE of N/A. Regarding short-term risk, KMVAX and GFAFX have similar daily volatility (0.00).Check GFAFX's competition here
KMVAX vs CGFAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, CGFAX has a market cap of 247.9B. Regarding current trading prices, KMVAX is priced at $35.77, while CGFAX trades at $72.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas CGFAX's P/E ratio is 26.44. In terms of profitability, KMVAX's ROE is N/A, compared to CGFAX's ROE of N/A. Regarding short-term risk, KMVAX and CGFAX have similar daily volatility (0.00).Check CGFAX's competition here
KMVAX vs VTV Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VTV has a market cap of 242B. Regarding current trading prices, KMVAX is priced at $35.77, while VTV trades at $196.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VTV's P/E ratio is 20.78. In terms of profitability, KMVAX's ROE is N/A, compared to VTV's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to VTV. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check VTV's competition here
KMVAX vs VVIAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VVIAX has a market cap of 238.5B. Regarding current trading prices, KMVAX is priced at $35.77, while VVIAX trades at $76.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VVIAX's P/E ratio is 20.45. In terms of profitability, KMVAX's ROE is N/A, compared to VVIAX's ROE of +0.00%. Regarding short-term risk, KMVAX and VVIAX have similar daily volatility (0.00).Check VVIAX's competition here
KMVAX vs FCTDX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FCTDX has a market cap of 221B. Regarding current trading prices, KMVAX is priced at $35.77, while FCTDX trades at $19.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FCTDX's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to FCTDX's ROE of N/A. Regarding short-term risk, KMVAX and FCTDX have similar daily volatility (0.00).Check FCTDX's competition here
KMVAX vs RGABX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RGABX has a market cap of 220.9B. Regarding current trading prices, KMVAX is priced at $35.77, while RGABX trades at $64.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RGABX's P/E ratio is 26.39. In terms of profitability, KMVAX's ROE is N/A, compared to RGABX's ROE of N/A. Regarding short-term risk, KMVAX and RGABX have similar daily volatility (0.00).Check RGABX's competition here
KMVAX vs RGAAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RGAAX has a market cap of 216.9B. Regarding current trading prices, KMVAX is priced at $35.77, while RGAAX trades at $63.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RGAAX's P/E ratio is 26.39. In terms of profitability, KMVAX's ROE is N/A, compared to RGAAX's ROE of N/A. Regarding short-term risk, KMVAX and RGAAX have similar daily volatility (0.00).Check RGAAX's competition here
KMVAX vs VO Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VO has a market cap of 213.6B. Regarding current trading prices, KMVAX is priced at $35.77, while VO trades at $287.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VO's P/E ratio is 22.72. In terms of profitability, KMVAX's ROE is N/A, compared to VO's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to VO. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check VO's competition here
KMVAX vs GFACX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, GFACX has a market cap of 211.1B. Regarding current trading prices, KMVAX is priced at $35.77, while GFACX trades at $61.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas GFACX's P/E ratio is 26.40. In terms of profitability, KMVAX's ROE is N/A, compared to GFACX's ROE of N/A. Regarding short-term risk, KMVAX and GFACX have similar daily volatility (0.00).Check GFACX's competition here
KMVAX vs ODIDX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, ODIDX has a market cap of 210.8B. Regarding current trading prices, KMVAX is priced at $35.77, while ODIDX trades at $8.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas ODIDX's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to ODIDX's ROE of N/A. Regarding short-term risk, KMVAX and ODIDX have similar daily volatility (0.00).Check ODIDX's competition here
KMVAX vs VMCIX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VMCIX has a market cap of 210.3B. Regarding current trading prices, KMVAX is priced at $35.77, while VMCIX trades at $78.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VMCIX's P/E ratio is 22.23. In terms of profitability, KMVAX's ROE is N/A, compared to VMCIX's ROE of +0.00%. Regarding short-term risk, KMVAX and VMCIX have similar daily volatility (0.00).Check VMCIX's competition here
KMVAX vs VMCPX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VMCPX has a market cap of 210.3B. Regarding current trading prices, KMVAX is priced at $35.77, while VMCPX trades at $387.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VMCPX's P/E ratio is 22.23. In terms of profitability, KMVAX's ROE is N/A, compared to VMCPX's ROE of +0.00%. Regarding short-term risk, KMVAX and VMCPX have similar daily volatility (0.00).Check VMCPX's competition here
KMVAX vs VIMAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VIMAX has a market cap of 210.3B. Regarding current trading prices, KMVAX is priced at $35.77, while VIMAX trades at $355.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VIMAX's P/E ratio is 22.23. In terms of profitability, KMVAX's ROE is N/A, compared to VIMAX's ROE of +0.00%. Regarding short-term risk, KMVAX and VIMAX have similar daily volatility (0.00).Check VIMAX's competition here
KMVAX vs LACG Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, LACG has a market cap of 209.6B. Regarding current trading prices, KMVAX is priced at $35.77, while LACG trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas LACG's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to LACG's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to LACG. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check LACG's competition here
KMVAX vs MER-PK Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, MER-PK has a market cap of 193.7B. Regarding current trading prices, KMVAX is priced at $35.77, while MER-PK trades at $25.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas MER-PK's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to MER-PK's ROE of +0.05%. Regarding short-term risk, KMVAX is less volatile compared to MER-PK. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check MER-PK's competition here
KMVAX vs IEFA Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, IEFA has a market cap of 189.1B. Regarding current trading prices, KMVAX is priced at $35.77, while IEFA trades at $90.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas IEFA's P/E ratio is 17.67. In terms of profitability, KMVAX's ROE is N/A, compared to IEFA's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to IEFA. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check IEFA's competition here
KMVAX vs VB Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VB has a market cap of 177.6B. Regarding current trading prices, KMVAX is priced at $35.77, while VB trades at $261.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VB's P/E ratio is 20.49. In terms of profitability, KMVAX's ROE is N/A, compared to VB's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to VB. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check VB's competition here
KMVAX vs FFICX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FFICX has a market cap of 177.3B. Regarding current trading prices, KMVAX is priced at $35.77, while FFICX trades at $59.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FFICX's P/E ratio is 25.34. In terms of profitability, KMVAX's ROE is N/A, compared to FFICX's ROE of N/A. Regarding short-term risk, KMVAX and FFICX have similar daily volatility (0.00).Check FFICX's competition here
KMVAX vs AICCX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AICCX has a market cap of 177.3B. Regarding current trading prices, KMVAX is priced at $35.77, while AICCX trades at $58.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AICCX's P/E ratio is 25.35. In terms of profitability, KMVAX's ROE is N/A, compared to AICCX's ROE of N/A. Regarding short-term risk, KMVAX and AICCX have similar daily volatility (0.00).Check AICCX's competition here
KMVAX vs CICAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, CICAX has a market cap of 176.8B. Regarding current trading prices, KMVAX is priced at $35.77, while CICAX trades at $59.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas CICAX's P/E ratio is 25.35. In terms of profitability, KMVAX's ROE is N/A, compared to CICAX's ROE of N/A. Regarding short-term risk, KMVAX and CICAX have similar daily volatility (0.00).Check CICAX's competition here
KMVAX vs AIVSX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AIVSX has a market cap of 176.8B. Regarding current trading prices, KMVAX is priced at $35.77, while AIVSX trades at $59.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AIVSX's P/E ratio is 25.35. In terms of profitability, KMVAX's ROE is N/A, compared to AIVSX's ROE of N/A. Regarding short-term risk, KMVAX and AIVSX have similar daily volatility (0.00).Check AIVSX's competition here
KMVAX vs AICFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AICFX has a market cap of 176.8B. Regarding current trading prices, KMVAX is priced at $35.77, while AICFX trades at $59.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AICFX's P/E ratio is 25.34. In terms of profitability, KMVAX's ROE is N/A, compared to AICFX's ROE of N/A. Regarding short-term risk, KMVAX and AICFX have similar daily volatility (0.00).Check AICFX's competition here
KMVAX vs RICBX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RICBX has a market cap of 176.8B. Regarding current trading prices, KMVAX is priced at $35.77, while RICBX trades at $58.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RICBX's P/E ratio is 25.35. In terms of profitability, KMVAX's ROE is N/A, compared to RICBX's ROE of N/A. Regarding short-term risk, KMVAX and RICBX have similar daily volatility (0.00).Check RICBX's competition here
KMVAX vs RICAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RICAX has a market cap of 176.8B. Regarding current trading prices, KMVAX is priced at $35.77, while RICAX trades at $58.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RICAX's P/E ratio is 25.35. In terms of profitability, KMVAX's ROE is N/A, compared to RICAX's ROE of N/A. Regarding short-term risk, KMVAX and RICAX have similar daily volatility (0.00).Check RICAX's competition here
KMVAX vs VSMAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VSMAX has a market cap of 173.8B. Regarding current trading prices, KMVAX is priced at $35.77, while VSMAX trades at $125.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VSMAX's P/E ratio is 19.86. In terms of profitability, KMVAX's ROE is N/A, compared to VSMAX's ROE of +0.00%. Regarding short-term risk, KMVAX and VSMAX have similar daily volatility (0.00).Check VSMAX's competition here
KMVAX vs VSCIX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VSCIX has a market cap of 173.8B. Regarding current trading prices, KMVAX is priced at $35.77, while VSCIX trades at $125.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VSCIX's P/E ratio is 19.86. In terms of profitability, KMVAX's ROE is N/A, compared to VSCIX's ROE of +0.00%. Regarding short-term risk, KMVAX and VSCIX have similar daily volatility (0.00).Check VSCIX's competition here
KMVAX vs C-PN Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, C-PN has a market cap of 172.1B. Regarding current trading prices, KMVAX is priced at $35.77, while C-PN trades at $29.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas C-PN's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to C-PN's ROE of +0.07%. Regarding short-term risk, KMVAX is less volatile compared to C-PN. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check C-PN's competition here
KMVAX vs FCNKX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FCNKX has a market cap of 169.7B. Regarding current trading prices, KMVAX is priced at $35.77, while FCNKX trades at $23.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FCNKX's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to FCNKX's ROE of N/A. Regarding short-term risk, KMVAX and FCNKX have similar daily volatility (0.00).Check FCNKX's competition here
KMVAX vs FCNTX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FCNTX has a market cap of 169.3B. Regarding current trading prices, KMVAX is priced at $35.77, while FCNTX trades at $22.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FCNTX's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to FCNTX's ROE of +0.00%. Regarding short-term risk, KMVAX and FCNTX have similar daily volatility (0.00).Check FCNTX's competition here
KMVAX vs FUNFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FUNFX has a market cap of 166.7B. Regarding current trading prices, KMVAX is priced at $35.77, while FUNFX trades at $88.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FUNFX's P/E ratio is 25.07. In terms of profitability, KMVAX's ROE is N/A, compared to FUNFX's ROE of N/A. Regarding short-term risk, KMVAX and FUNFX have similar daily volatility (0.00).Check FUNFX's competition here
KMVAX vs CFNAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, CFNAX has a market cap of 166.7B. Regarding current trading prices, KMVAX is priced at $35.77, while CFNAX trades at $88.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas CFNAX's P/E ratio is 25.08. In terms of profitability, KMVAX's ROE is N/A, compared to CFNAX's ROE of N/A. Regarding short-term risk, KMVAX and CFNAX have similar daily volatility (0.00).Check CFNAX's competition here
KMVAX vs ANWPX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, ANWPX has a market cap of 165.6B. Regarding current trading prices, KMVAX is priced at $35.77, while ANWPX trades at $66.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas ANWPX's P/E ratio is 24.15. In terms of profitability, KMVAX's ROE is N/A, compared to ANWPX's ROE of N/A. Regarding short-term risk, KMVAX and ANWPX have similar daily volatility (0.00).Check ANWPX's competition here
KMVAX vs ANCFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, ANCFX has a market cap of 165.6B. Regarding current trading prices, KMVAX is priced at $35.77, while ANCFX trades at $88.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas ANCFX's P/E ratio is 25.07. In terms of profitability, KMVAX's ROE is N/A, compared to ANCFX's ROE of N/A. Regarding short-term risk, KMVAX and ANCFX have similar daily volatility (0.00).Check ANCFX's competition here
KMVAX vs AFIFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AFIFX has a market cap of 165.6B. Regarding current trading prices, KMVAX is priced at $35.77, while AFIFX trades at $88.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AFIFX's P/E ratio is 25.08. In terms of profitability, KMVAX's ROE is N/A, compared to AFIFX's ROE of N/A. Regarding short-term risk, KMVAX and AFIFX have similar daily volatility (0.00).Check AFIFX's competition here
KMVAX vs FINFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FINFX has a market cap of 165.6B. Regarding current trading prices, KMVAX is priced at $35.77, while FINFX trades at $88.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FINFX's P/E ratio is 25.07. In terms of profitability, KMVAX's ROE is N/A, compared to FINFX's ROE of N/A. Regarding short-term risk, KMVAX and FINFX have similar daily volatility (0.00).Check FINFX's competition here
KMVAX vs RFNCX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RFNCX has a market cap of 165.6B. Regarding current trading prices, KMVAX is priced at $35.77, while RFNCX trades at $88.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RFNCX's P/E ratio is 25.07. In terms of profitability, KMVAX's ROE is N/A, compared to RFNCX's ROE of N/A. Regarding short-term risk, KMVAX and RFNCX have similar daily volatility (0.00).Check RFNCX's competition here
KMVAX vs RNPCX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RNPCX has a market cap of 165.3B. Regarding current trading prices, KMVAX is priced at $35.77, while RNPCX trades at $64.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RNPCX's P/E ratio is 24.13. In terms of profitability, KMVAX's ROE is N/A, compared to RNPCX's ROE of N/A. Regarding short-term risk, KMVAX and RNPCX have similar daily volatility (0.00).Check RNPCX's competition here
KMVAX vs RNPGX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RNPGX has a market cap of 165.3B. Regarding current trading prices, KMVAX is priced at $35.77, while RNPGX trades at $66.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RNPGX's P/E ratio is 24.17. In terms of profitability, KMVAX's ROE is N/A, compared to RNPGX's ROE of N/A. Regarding short-term risk, KMVAX and RNPGX have similar daily volatility (0.00).Check RNPGX's competition here
KMVAX vs FNPFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FNPFX has a market cap of 165.3B. Regarding current trading prices, KMVAX is priced at $35.77, while FNPFX trades at $66.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FNPFX's P/E ratio is 24.17. In terms of profitability, KMVAX's ROE is N/A, compared to FNPFX's ROE of N/A. Regarding short-term risk, KMVAX and FNPFX have similar daily volatility (0.00).Check FNPFX's competition here
KMVAX vs NPFFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, NPFFX has a market cap of 165.3B. Regarding current trading prices, KMVAX is priced at $35.77, while NPFFX trades at $66.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas NPFFX's P/E ratio is 24.15. In terms of profitability, KMVAX's ROE is N/A, compared to NPFFX's ROE of N/A. Regarding short-term risk, KMVAX and NPFFX have similar daily volatility (0.00).Check NPFFX's competition here
KMVAX vs VWO Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VWO has a market cap of 162.3B. Regarding current trading prices, KMVAX is priced at $35.77, while VWO trades at $54.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VWO's P/E ratio is 14.60. In terms of profitability, KMVAX's ROE is N/A, compared to VWO's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to VWO. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check VWO's competition here
KMVAX vs VEMRX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VEMRX has a market cap of 158.4B. Regarding current trading prices, KMVAX is priced at $35.77, while VEMRX trades at $112.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VEMRX's P/E ratio is 14.13. In terms of profitability, KMVAX's ROE is N/A, compared to VEMRX's ROE of +0.00%. Regarding short-term risk, KMVAX and VEMRX have similar daily volatility (0.00).Check VEMRX's competition here
KMVAX vs VEMAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, VEMAX has a market cap of 158.4B. Regarding current trading prices, KMVAX is priced at $35.77, while VEMAX trades at $44.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas VEMAX's P/E ratio is 14.13. In terms of profitability, KMVAX's ROE is N/A, compared to VEMAX's ROE of +0.00%. Regarding short-term risk, KMVAX and VEMAX have similar daily volatility (0.00).Check VEMAX's competition here
KMVAX vs GLD Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, GLD has a market cap of 157.5B. Regarding current trading prices, KMVAX is priced at $35.77, while GLD trades at $430.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas GLD's P/E ratio is -45.81. In terms of profitability, KMVAX's ROE is N/A, compared to GLD's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to GLD. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check GLD's competition here
KMVAX vs FPMAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FPMAX has a market cap of 153.8B. Regarding current trading prices, KMVAX is priced at $35.77, while FPMAX trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FPMAX's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to FPMAX's ROE of N/A. Regarding short-term risk, KMVAX and FPMAX have similar daily volatility (0.00).Check FPMAX's competition here
KMVAX vs IEMG Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, IEMG has a market cap of 152.4B. Regarding current trading prices, KMVAX is priced at $35.77, while IEMG trades at $69.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas IEMG's P/E ratio is 14.99. In terms of profitability, KMVAX's ROE is N/A, compared to IEMG's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to IEMG. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check IEMG's competition here
KMVAX vs BLK Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, BLK has a market cap of 149.6B. Regarding current trading prices, KMVAX is priced at $35.77, while BLK trades at $961.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas BLK's P/E ratio is 27.24. In terms of profitability, KMVAX's ROE is N/A, compared to BLK's ROE of +0.11%. Regarding short-term risk, KMVAX is less volatile compared to BLK. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check BLK's competition here
KMVAX vs FIFAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FIFAX has a market cap of 149.2B. Regarding current trading prices, KMVAX is priced at $35.77, while FIFAX trades at $26.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FIFAX's P/E ratio is 18.67. In terms of profitability, KMVAX's ROE is N/A, compared to FIFAX's ROE of N/A. Regarding short-term risk, KMVAX and FIFAX have similar daily volatility (0.00).Check FIFAX's competition here
KMVAX vs WGIFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, WGIFX has a market cap of 148.7B. Regarding current trading prices, KMVAX is priced at $35.77, while WGIFX trades at $70.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas WGIFX's P/E ratio is 22.17. In terms of profitability, KMVAX's ROE is N/A, compared to WGIFX's ROE of N/A. Regarding short-term risk, KMVAX and WGIFX have similar daily volatility (0.00).Check WGIFX's competition here
KMVAX vs GRAG Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, GRAG has a market cap of 148.6B. Regarding current trading prices, KMVAX is priced at $35.77, while GRAG trades at $6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas GRAG's P/E ratio is N/A. In terms of profitability, KMVAX's ROE is N/A, compared to GRAG's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to GRAG. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check GRAG's competition here
KMVAX vs AEGFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AEGFX has a market cap of 141.5B. Regarding current trading prices, KMVAX is priced at $35.77, while AEGFX trades at $58.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AEGFX's P/E ratio is 18.32. In terms of profitability, KMVAX's ROE is N/A, compared to AEGFX's ROE of N/A. Regarding short-term risk, KMVAX and AEGFX have similar daily volatility (0.00).Check AEGFX's competition here
KMVAX vs RERHX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RERHX has a market cap of 141.5B. Regarding current trading prices, KMVAX is priced at $35.77, while RERHX trades at $58.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RERHX's P/E ratio is 18.34. In terms of profitability, KMVAX's ROE is N/A, compared to RERHX's ROE of N/A. Regarding short-term risk, KMVAX and RERHX have similar daily volatility (0.00).Check RERHX's competition here
KMVAX vs AEPFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AEPFX has a market cap of 141.5B. Regarding current trading prices, KMVAX is priced at $35.77, while AEPFX trades at $58.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AEPFX's P/E ratio is 18.34. In terms of profitability, KMVAX's ROE is N/A, compared to AEPFX's ROE of N/A. Regarding short-term risk, KMVAX and AEPFX have similar daily volatility (0.00).Check AEPFX's competition here
KMVAX vs RERGX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RERGX has a market cap of 141.3B. Regarding current trading prices, KMVAX is priced at $35.77, while RERGX trades at $58.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RERGX's P/E ratio is 18.34. In terms of profitability, KMVAX's ROE is N/A, compared to RERGX's ROE of N/A. Regarding short-term risk, KMVAX and RERGX have similar daily volatility (0.00).Check RERGX's competition here
KMVAX vs AEPGX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AEPGX has a market cap of 141.3B. Regarding current trading prices, KMVAX is priced at $35.77, while AEPGX trades at $58.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AEPGX's P/E ratio is 18.33. In terms of profitability, KMVAX's ROE is N/A, compared to AEPGX's ROE of N/A. Regarding short-term risk, KMVAX and AEPGX have similar daily volatility (0.00).Check AEPGX's competition here
KMVAX vs AGG Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AGG has a market cap of 138.9B. Regarding current trading prices, KMVAX is priced at $35.77, while AGG trades at $99.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AGG's P/E ratio is 126.64. In terms of profitability, KMVAX's ROE is N/A, compared to AGG's ROE of +0.00%. Regarding short-term risk, KMVAX is less volatile compared to AGG. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check AGG's competition here
KMVAX vs AWSHX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, AWSHX has a market cap of 138.3B. Regarding current trading prices, KMVAX is priced at $35.77, while AWSHX trades at $62.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas AWSHX's P/E ratio is 24.16. In terms of profitability, KMVAX's ROE is N/A, compared to AWSHX's ROE of N/A. Regarding short-term risk, KMVAX and AWSHX have similar daily volatility (0.00).Check AWSHX's competition here
KMVAX vs RWMFX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, RWMFX has a market cap of 138.2B. Regarding current trading prices, KMVAX is priced at $35.77, while RWMFX trades at $62.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas RWMFX's P/E ratio is 24.16. In terms of profitability, KMVAX's ROE is N/A, compared to RWMFX's ROE of N/A. Regarding short-term risk, KMVAX and RWMFX have similar daily volatility (0.00).Check RWMFX's competition here
KMVAX vs FWMIX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, FWMIX has a market cap of 138.1B. Regarding current trading prices, KMVAX is priced at $35.77, while FWMIX trades at $62.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas FWMIX's P/E ratio is 24.16. In terms of profitability, KMVAX's ROE is N/A, compared to FWMIX's ROE of N/A. Regarding short-term risk, KMVAX and FWMIX have similar daily volatility (0.00).Check FWMIX's competition here
KMVAX vs BX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, BX has a market cap of 138.1B. Regarding current trading prices, KMVAX is priced at $35.77, while BX trades at $114.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas BX's P/E ratio is 29.71. In terms of profitability, KMVAX's ROE is N/A, compared to BX's ROE of +0.36%. Regarding short-term risk, KMVAX is less volatile compared to BX. This indicates potentially lower risk in terms of short-term price fluctuations for KMVAX.Check BX's competition here
KMVAX vs CWMAX Comparison April 2026
KMVAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KMVAX stands at 108.7M. In comparison, CWMAX has a market cap of 137.8B. Regarding current trading prices, KMVAX is priced at $35.77, while CWMAX trades at $62.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KMVAX currently has a P/E ratio of N/A, whereas CWMAX's P/E ratio is 24.16. In terms of profitability, KMVAX's ROE is N/A, compared to CWMAX's ROE of N/A. Regarding short-term risk, KMVAX and CWMAX have similar daily volatility (0.00).Check CWMAX's competition here